首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Signal transduction and targeted therapy

缩写:

ISSN:2095-9907

e-ISSN:2059-3635

IF/分区:52.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2606
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Longjie Huangfu,Ruiying Li,Yamei Huang et al. Longjie Huangfu et al.
The interleukin-17 (IL-17) family comprises six members (IL-17A-17F), and recently, all of its related receptors have been discovered. IL-17 was first discovered approximately 30 years ago. Members of this family have various biological fun...
Xia Xu,Tao Yu,Lingling Dong et al. Xia Xu et al.
Patients with chronic obstructive pulmonary disease (COPD) who exhibit elevated blood eosinophil levels often experience worsened lung function and more severe emphysema. This implies the potential involvement of eosinophils in the developm...
Ming Liu,Bingtai Lu,Yue Li et al. Ming Liu et al.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has had a significant impact on healthcare systems and economies worldwide. The continuous emergence of new viral stra...
Qing Zhao,Yao Chen,Weihua Huang et al. Qing Zhao et al.
Individual variability in drug response (IVDR) can be a major cause of adverse drug reactions (ADRs) and prolonged therapy, resulting in a substantial health and economic burden. Despite extensive research in pharmacogenomics regarding the ...
Rongzhang He,Xingyu Zheng,Jian Zhang et al. Rongzhang He et al.
Long-term humoral immunity to SARS-CoV-2 is essential for preventing reinfection. The production of neutralizing antibody (nAb) and B cell differentiation are tightly regulated by T follicular help (TFH) cells. However, the longevity and fu...
Ying Fang,Mu-Chen Zhang,Yang He et al. Ying Fang et al.
TP53 mutation (TP53mut) occurs in 10-20% of diffuse large B-cell lymphoma (DLBCL) cases and serves as an unfavorable biomarker of DLBCL progression. It confers resistance to immunochemotherapy, high-dose chemotherapy, autologous stem cell t...